INTRODUCTION
Cerebellar malformations are rare developmental disorders that comprise many heterogeneous diseases, with both acquired and genetic causes. 1 They can be confined to the cerebellum or variably involve other infratentorial or supratentorial structures, such as the brainstem, the corpus callosum and the cerebral cortex. 2 The cerebellum is usually hypoplastic, at difference from neurodegenerative disorders, in which progressive cerebellar atrophy is observed.
Nevertheless, the distinction between cerebellar hypoplasia and cerebellar atrophy is not always clearcut as secondary atrophy may occur in a hypoplastic cerebellum. Both syndromic and pure forms of cerebellar hypoplasia are known. The clinical spectrum associated with cerebellar hypoplasia varies according to the aetiology, and includes non-progressive congenital ataxia (NPCA), abnormal ocular movements and, less frequently, hypotonia. Besides motor deficits, clinical features may include developmental delay, cognitive impairment, deficit of executive functions, language deficits and mood disorders, including autistic-like behaviour. 3 The genetic component has been partially defined in recent years, and autosomal recessive, autosomal dominant or X-linked inheritance has been reported (http://neuromuscular.wustl. edu/ataxia/recatax.html#congenital). At least 15 syndromes with cerebellar hypoplasia have X-linked inheritance. For some of them causative genes have been identified (eg, OPHN1, DKC1, CASK and CUL4B), 4 5 while two additional loci have been mapped to Xp11.21-Xq24 6 7 and Xq25-q27. 1, 8 respectively.
Here we report the detailed investigation, starting from the abnormal karyotype, in a child affected by cerebellar hypoplasia, NPCA and psychomotor delay. Cytogenetic and breakpoint analyses led to the identification of genes potentially involved in the disease, a role corroborated by functional analyses.
MATERIALS AND METHODS
Subjects, cell lines, and extraction of genomic DNA and total RNA Peripheral blood lymphocytes (PBL) were obtained from the patient and her parents. PBL were used to create immortalised lymphoblastoid cell lines (LCL) by Epstein-Barr Virus (EBV) transformation. Fibroblasts were obtained from dermal biopsy of the patient and three healthy gender-matched adult controls. Informed consent was obtained for the patient and her parents. Genomic DNA was extracted from peripheral blood (Qiagen, Hilden, Germany) following the manufacturer's instructions. Total RNA was extracted from lymphoblasts or fibroblasts using an RNeasy Plus Mini Kit (Qiagen), and retro-transcribed using the Transcriptor First Strand cDNA Synthesis kit (Roche Diagnostics, Mannheim, Germany).
Cytogenetic, fluorescence in situ Hybridisation (FISH) analyses, array-CGH Cytogenetic analysis of PBL from the proband and from both parents was performed using standard techniques. Array-CGH was carried out on genomic DNA using a whole genome oligonucleotide microarray platform (Human Genome CGH Microarray 244A Kit; Agilent Technologies, Santa Clara, California, USA) (see online supplement).
Mice tissue collection and RNA isolation
Thoc2 and Ptk2 mRNA quantification was performed on tissues obtained from C57BL/6 mice at different ages from embryonic day 14 (E14) to 2 months postnatal (P60), including the day of birth (P0) ( pools of three individuals per time point) (see online supplement).
In vitro transcription/translation
To obtain the chimeric PTK2-THOC2 transcript, we amplified the patient's cDNA using a forward primer on exon 1 of the PTK2 gene and a reverse primer on exon 12 of the THOC2 gene. Transcription/translation was performed using TnT T7 Quick for PCR as described (Promega) (see online supplement).
Caenorhabditis elegans models, nematode strains, maintenance and gene silencing Strains utilised in this work were N2:wild-type Bristol, RB776: kin-32(ok166) I, and VC673: thoc-2(ok961) III/hT2(bli-4(e937) let-?(q782) qIs48) (I;III). We employed standard nematode culture conditions. 9 Strains were maintained at 20°C on Nematode Growth Media agar supplemented with Escherichia coli (OP50 or transformed HT115). Gene silencing was carried out through the RNA interference feeding technique as previously described 10 using bacteria transformed with L4440 empty vector as control, or L4440 containing dsRNA against kin-32 (C30F8.4), or thoc-2 (C16A3.8). Functional assays were performed as described in the online supplement.
PTK2 expression induction
Patient's fibroblast cells (2×10 4 ) were plated on 24-well plates, cultured overnight, treated with 50 ng/ml of TNF-α ( p.n. T6674, Sigma-Aldrich, St. Louis, Missouri, USA) for 6 h. Total RNA was collected using the Cells-to-Ct kit (Applied Biosystem) according to the manufacturer's protocols. Messenger RNA levels of PTK2, PTK2-THOC2 fusion product and THOC2 were determined by real-time RT-PCR as described in the online supplement.
Rat hippocampal neurones and LC1 neuronal precursors culture and silencing Primary cultures of rat hippocampal neurones were prepared from rat embryonic brains at E17.5 as previously described. 9 For morphological analysis in the first stages of development,
5×10
5 neurones were nucleofected with Amaxa Nucleofection Kit (Lonza, Cologne, Germany). Neurones were plated in MEM-Horse medium on poly-L-lysine pre-coated coverslips. After 4 h, medium was changed in N2 medium and coverslips were flipped upside down. For morphological analysis 2 × 10 5 neurones were plated.
LC1 were plated (typically 2-3 × 10 6 cells into a T75 flask) on uncoated plastic in Neuromed N medium (Euroclone, Milan, Italy) supplemented with modified N2 11 and 10 ng/ml of both EGF and FGF-2 (NS expansion medium). LC1 were detached with Accutase (Invitrogen), pelleted in PBS and then split into fresh plates. For transfection 8 × 10 6 cells were nucleofected with Amaxa Nucleofection Kit.
For transfection in hippocampal neurones and LC1 we used two efficient Thoc2 siRNA constructs (Sh8137 and Sh2113, Ambion).
Rat hippocampal neurones grown on coverslips were fixed with 4% paraformaldehyde (PFA)/PBS for 10 min, then quenched with NH 4 Cl 50 mM/PBS. Permeabilisation was performed with 0.1% TritonX-100/PBS for 3 min and a 5% BSA/ PBS saturation was left for 30 min over the coverslips. Following this step, primary antibodies were left for 1 h and appropriate Alexa-conjugated secondary antibodies were used for 30 min followed by other three washings with PBS. Coverslips were mounted with Mowiol on cover glasses and analysed with an inverted fluorescence microscope. All samples were examined using Apotome system (Zeiss).
The following primary antibodies were used: mouse monoclonal anti-SMI 312 (Covance), mouse monoclonal anti-α Tubulin (Sigma), counterstaining using Phalloidin (Sigma) for actin and DAPI (Sigma) for nuclei.
Further Materials and Methods are in the online supplement.
RESULTS

Clinical, neuroradiological, biochemical and genetic analyses
The patient was born after an uneventful pregnancy. No problems were reported at birth, in the perinatal period and during the first year of life. Symptoms were noted at ∼15 months when she started walking, and consisted of motor incoordination and unsteady gait. Brain MRI at 23 months revealed hypoplasia of the cerebellar hemispheres and vermis. MRI was repeated at ∼ 6 years and corfirmed hypoplasia of the posterior fossa with low-set tentorium, not progressive over time. Both cerebellar hemispheres and vermis were hypoplastic with enlargement of the IV ventricle (figure 1A and see online supplementary figure S1). At 8 years the patient underwent detailed clinical investigation. Electrocardiogram was normal. Mild dysmorphic features were noted: joint hypermobility, micrognathia leading to malocclusion, ogival palate, pointed chin, low-set and protruding ears, small hands (10th centile) with tapering fingers and clinodactyly of the 4th finger and hyperconvex toenails.
Neurological features included gait and limb ataxia, dysmetria, adiadochokinesia and diffuse hypothonia. The patient also presented with bradylalia, dysarthria, occasional dyslalia and pneumophonic coordination impairment. Babinski sign was present on the left foot only; osteotendinous reflexes were weak at the four limbs. Eye movements were normal and nystagmus was absent. Mild intellectual disability was present, with impaired visual and spatial orientation. Moreover, aggressive behaviour and socially inappropriate and derogatory remarks (coprolalia) were reported. Biochemical blood analyses were normal. Serum α-fetoprotein was within normal range.
Sialoglycoprotein deficits were ruled out by laboratory testing. Friedreich's ataxia was excluded by routine genetic testing.
Cytogenetic analysis
Chromosome analysis found a translocation involving chromosomes X and 8: 46,X,t(X;8)(q25;q24.3) (figure 1B). The normal karyotype of the parents and the segregation of polymorphic markers (Profiler Plus kit, Applied Biosystems) demonstrated that the translocation was de novo. FISH analysis with probes painting the X chromosome confirmed the translocation (data not shown), and a subtelomeric 8q probe (Vysis) proved that a small telomeric 8q region was translocated on the der(X) chromosome. Array-CGH analysis using a 244 K array (Agilent Technologies) did not reveal genomic deletion/duplication besides a few known copy number variants.
X-inactivation was completely skewed in the proband (see online supplementary figure S1C), with the active allele inherited from the father.
Mapping and characterisation of the breakpoint junctions
We mapped the breakpoint to a region of ∼37 kb and defined the translocation between 8q24.3 and Xq25 by FISH (see online supplementary figure S1D and S1E).
We used a set of forward and reverse primers to amplify the breakpoint junctions on the two derivatives. The two breakpoints were located in nonhomologous regions, involving repetitive elements: MER4/AluJ on chromosome 8 and SINE, VNTR and Alu (SVA) element on chromosome X (see online supplementary figure S2). A segment of 88 bp was lost on the X chromosome in the translocation.
The translocation interrupted the PTK2 gene at 8q24.3 in the 5 0 -UTR between exons 1 and 2, ∼30 kb from the transcription start site (TSS), whereas no known gene was interrupted at Xq25. However, the TSS of the closest gene, THOC2, lay only 2 kb downstream of the breakpoint (see scheme in figure 1E ).
PTK2 and THOC2 gene expression analyses
We initially evaluated PTK2 gene expression by mRNA and protein analysis. We showed that the rs7460 SNP, heterozygous in the patient's genomic DNA, was expressed only from the paternal allele (figure 2A). Real-time PCR on total RNA from fibroblasts showed a half-dose of the PTK2 gene in the patient (0.5±0.05, mean±S.D.) compared to normal controls (1.0 ±0.1, mean±SD, p<0.001) (figure 2B). Western blot confirmed protein reduction in the patient (0.7±0.1, mean±SD) versus controls (1.0±0.05, mean±SD) (figure 2C). THOC2 showed an apparent mRNA overexpression ( patient=2.8±0.025, mean±S.D., controls=1±0.06, p<0.001) with a real-time PCR assay on exons 33-34 from patient's fibroblasts (figure 2D). However, using an assay on exons 1-2 of the THOC2 gene revealed a transcript reduction to about half the dose of controls ( patient=0.5±0.035, mean±S.D.; controls=1 ±0.06, p<0.01) (figure 2D) THOC2 protein levels were also significantly reduced ( patient=0.4±0.1, mean±S.D., controls=1±0.9, p<0.01, twotailed Student's t test) ( figure 2E) .
To test the effect of the translocation on THOC2 flanking genes, we measured the expression of GRIA3 ( patient=0.97 ±0.04, controls=1±0.05, mean±S.D.) and XIAP ( patient 0.93 ±0.10, controls 1±0.08, mean±S.D.) versus TBP in the patient's fibroblasts. Expression of both genes was similar to controls.
We reasoned that even if the breakpoint on the der(X) lay outside the THOC2 coding sequence, it could alter THOC2 expression by transcriptional interference.
PTK2-THOC2 fusion sterile transcript
The above results suggested that two different mRNAs were produced from the der(X): a less abundant, corresponding to the wild-type transcript, initiated at the THOC2 TSS, and a more abundant, fusion transcript under the control of the PTK2 promoter. The fusion transcript was confirmed by RT-PCR on RNA from the patient's fibroblasts, using a forward primer within PTK2 exon 1, and a reverse primer in THOC2 exon 2 ( figure 3A) . The sequence of the PCR product showed the skipping of THOC2 exon 1, likely because the first exon does not have an acceptor splice site (see scheme in figure 3A) . The expected sterility of the fusion transcript was confirmed in vitro through a coupled transcription/translation assay: as shown in figure 3B , the 45.7 kDa protein produced in the control lane was absent in the transcribed and translated PTK2-THOC2 construct (see also online supplement).
PTK2 promoter transcriptional interference on THOC2
To evaluate whether expression of the fusion transcript affected expression of the wild-type PTK2 allele, we treated the patient's fibroblasts with 50 ng/ml TNF-α for 6 h, known to induce PTK2 expression.
12 By real-time PCR, we measured expression of wild-type PTK2, wild-type THOC2 (exons 1-2) and the sum of wild-type THOC2 and the fusion transcript (with an assay on THOC2 exons 33-34). Under these conditions, wild-type PTK2 However, using an assay on the 3 0 -end of the gene, THOC2 transcript is apparently increased (***p<0.001, assay on exons 33-34). (E) THOC2 reduction was confirmed at protein level versus β actin (ACTB) (**p<0.01). Statistic analysis was performed using a two-tailed Student's t test.
mRNA was significantly induced (untreated cells=1±0.032, mean±SD, treated cells=1.5±0.048, p<0.001) ( figure 3C ). TNF-α also elicited a ∼60% increase in expression of total THOC2 mRNA (untreated cells 1±0.037, mean±S.D., treated cells 1.6±0.084, p<0.001), but at the same time produced ∼10% reduction of the wild-type THOC2 (untreated cells 1 ±0.034, mean±S.D., treated cells 0.9±0.016, p=0.0052) (figure 3C).
Ptk2 and Thoc2 expression in mouse brain
To better interpret the results obtained in the patient's cells, we investigated PTK2 and THOC2 function in cellular and animal models.
We measured Ptk2 and Thoc2 mRNA expression in murine brain and cerebellum at different developmental stages (E14, P0, P60) ( figure 4A,B) . Expression of both genes seemed to increase from embryonic to adult life in the two tissues. It has been shown by in situ hybridisation experiments using an antisense probe that Thoc2 is highly expressed in brain, especially in the frontal cortex, and selectively expressed in the cerebellar region corresponding to the Purkinje cell layer (figure 4C,D Allen Institute for Brain Science. ©2009. http://mouse. brain-map.org, experiment 69444837).
Kin-32 and thoc-2 models in C. elegans C. elegans has one THOC2 homologue known as thoc-2 or tag-13, and one PTK2 homologue known as kin-32. Kin-32 encodes, by alternative splicing, two isoforms of a focal adhesion kinase, orthologous to human PTK2 and PTK2B. 13 Consistent with previous findings, 13 we observed that kin-32 knockout animals were viable, fertile and did not show anomalies in development, locomotion or chemosensory activity. On the other hand, thoc-2 appears to be necessary for animal viability (http://www.wormbase.org). A strain containing a large, thoc-2 homozygous, lethal deletion toward the C-terminus of the thoc-2 gene (ok961) is therefore maintained as a balanced heterozygote with a bli-4 and GFP-marked translocation. C. elegans thoc-2 knockouts (25%) were slow-growing, became sterile adults with vulva defects (http://www.wormbase.org) and died prematurely (our unpublished observation). Animals thoc-2 +/+ (25%) were not viable due to segregation with the homozygous lethal bli-4 balancer; thoc-2 +/− were instead wild-type-looking animals, with normal fertility and slightly retarded development. Further experiments were therefore performed on thoc-2 +/− and thoc-2 −/− animals. Animals thoc-2 −/− were almost completely immobile, or moved slowly and for a short time upon touching. Locomotion was also statistically reduced in heterozygotes ( figure 5A ). On the other hand, mechanosensory neurones were not affected in either genotypes, as shown by a normal response to head and tail touch (data not shown). The chemotaxis index, tested in a mixed population of thoc-2 knockouts and heterozygotes, was significantly reduced for different attractants/repulsive chemicals, proving a defect in specific sensory neurones (figure 5B).
Thoc2 knockdown in mouse LC-1 cells and in rat hippocampal cells
The anatomical and functional abnormalities detected in the patient suggested that a reduced dosage of THOC2 could determine specific abnormalities in the proliferation, differentiation and/or survival of neuronal precursor cells or in the survival of differentiated neurones. To address these possibilities, we conducted knockdown studies in rodent cells transfected with shRNA constructs capable of reducing the Thoc2 ortholog expression by approximately 70% in HeLa cells (data not shown). To analyse the possible effects of Thoc2 knockdown on the expansion of neuronal precursors we used mouse LC-1 cells, which are positive for the neuronal progenitor marker nestin and rapidly proliferate in presence of FGF2 and EGF, but differentiate with high efficiency into neurones and astrocytes when cultured without growth factors. 11 On the other hand, to address the role of Thoc2 in neuronal differentiation, we resorted to rat The functionality of a specific subset of animal sensory neurones (AWA, AWB, AWC, ASE) was assessed by quantifying their attraction or repulsion to specific chemicals (respectively: pyrazine, nonanone, benzaldheide, NH 4 Acetate). Bars represent mean of data coming from two to four independent experiments, each time carried in duplicate from two independent operators; error bars represent SE of the mean (SEM); *p<0.05, ***p<0.001, two-tailed, unpaired Student's t test.
hippocampal neurones in primary culture. 14 These cells were transfected with shRNA constructs before plating and allowed to differentiate for ∼72 h. In both systems, Thoc2 silencing did not increase significantly the number of apoptotic cells (data not shown), thus excluding that Thoc2 knockdown affected neuronal cell viability. On the contrary, Thoc2-depleted LC-1 cells displayed a significantly increased proliferation rate, as determined by the MTT assay ( figure 6A ). In differentiating primary hippocampal neurones, the knockdown of Thoc2 produced a significant increase in the length of neuronal processes ( figure 6B,C) , without affecting the timing of transitions between the first differentiation stages (data not shown).
DISCUSSION
Chromosomal rearrangements have been instrumental in identifying disease-causing genes located across or near the breakpoints. 15 16 Here we describe a de novo reciprocal translocation between Xq25-ter and 8q24.3-ter, associated with psychomotor retardation and congenital cerebellar hypoplasia, likely caused by altered expression of two genes, PTK2 at 8q24.3 and THOC2 at Xq25. The 8q24.3 breakpoint occurred within the PTK2 gene. As expected, the mRNA and PTK2 protein levels were reduced to 50% in the patient's fibroblasts, compared to healthy controls. The absence of mutation in the transcript expressed by the second PTK2 allele does not support the hypothesis of a recessive phenotype. PTK2 encodes a cytosolic protein tyrosine kinase involved in focal adhesion formation. 17 Its activity elicits intracellular signal transduction pathways that stimulate the turnover of cell contacts with the extracellular matrix, promoting cell migration. PTK2 has been implicated in central nervous system development and myelination, and synaptic plasticity in the mouse hippocampus. 18 19 20 Although we cannot exclude that PTK2 haploinsufficiency played some role in our patient's phenotype, it is worth noting that: (a) microdeletions and macrodeletions (∼120 kb to 6.9 Mb) Figure 6 Thoc2 knockdown in LC1 neural precursor cells and rat hippocampal neurones. (A) Thoc2 knockdown stimulated the proliferation of LC1 neural precursor cells in culture. Neural precursor LC1 were electroporated with a scramble shRNA (shCTRL) or with specific shRNA expressing plasmid (sh2113) before plating, and allowed to proliferate in culture for 24 h, 48 h and 72 h. The proliferation rate was measured using the MTT assay. Thoc2 knockdown neurones grew faster than control cells ( p<0.05, two-tailed, paired Student's t test). (B, C) Primary rat hippocampal neurones were electroporated before plating with control (shCTRL) or specific shRNA-expressing plasmids (sh8137, sh2113) and allowed to differentiate for 3 days. The knockdown of Thoc2 gene stimulated neurite outgrowth (*p<0.05, **p<0.01, ***p<0.001, two-tailed, unpaired Student's t test). Green signal in the transfected cells is GFP and red signal is the staining for α-Tubulin (C). ; (c) kin-32 (PTK2 ortholog) silencing in C. elegans did not affect viability, development, fertility, locomotion and chemosensory activity.
The Xq25 translocation created a fusion product that maintained both the PTK2 and THOC2 promoters. We demonstrated that the transcription of the PTK2-THOC2 fusion gene, under the PTK2 promoter, downregulates the level of the wild-type THOC2 mRNA and protein.
Such a phenomenon, known as transcriptional interference, 23 is responsible of a variety of human diseases, for example, α-thalassemia (a gain-of-function, regulatory singlenucleotide polymorphism creates a new promoter-like element that interferes with normal activation of all downstream α-like globin genes 24 ); Lynch syndrome: TACSTD1-a gene upstream to the Mismatch repair MSH2 gene, transcribed in the same direction-not rarely shows deletions spanning the last exon, including the polyA signal. The RNA polymerase proceeds, interfering with the transcription of the downstream MSH2 promoter, and gives rise to TACSTD1/MSH2 fusion transcripts.
25
THOC2 product is a subunit of a multiprotein complex called the THO complex, which is conserved from yeast to humans. 26 THO interacts physically and functionally with the mRNA export factors Yra1 and Sub2 forming the TREX (TRanscription-EXport) complex.
It has been shown that TREX plays a role in mRNA transport from the nucleus to cytoplasm and distinct pathophysiological states are correlated with defective mRNA export mechanisms. 27 Thoc5 deletion in mice causes death in the first 2 weeks after birth, similar to Thoc1 deletion. Thoc5 conditional knockout mouse develops acute leukocytopenia and anaemia, suggesting that the TREX complex has a key role not only in early embryogenesis, but also in differentiation, as previously reported with Thoc1 knockout. 28 29 Other mRNA export genes have been linked to human diseases, such as the fragile X mental retardation protein, FMRP, that regulates mRNA metabolism and translation of key molecules involved in receptor signalling and spine morphology.
30
THOC2 is expressed in murine brain, and its pattern in the cerebellum is compatible with Purkinje cells distribution, consistent with our patient's clinic-pathological phenotype. PTK2 is also expressed in brain, but with a more diffuse pattern 22 . In the cerebellum, the generation of the different categories of neurones is accomplished through well-defined space and time constraints, regulated by signals that are only partially known 31 : downregulation of THOC2, possibly combined with PTK2 haploinsufficiency, may lead to aberrant timing of axonal sprouting or altered proliferation of specific neuronal populations, thus determining the cerebellar hypoplasia/cognitive impairment found in our patient.
Indeed, using fibroblasts from our patient, we demonstrated that when the PTK2 gene was upregulated by TNF-α, the fusion transcript was overexpressed, whereas wild-type THOC2 gene was further repressed. We suggest that THOC2 downregulation by transcriptional interference is a hypomorphic mutation and its expression may be further reduced in tissues where the ratio PTK2/THOC2 favours the former.
The possible role of THOC2 in the pathogenesis of our patient's phenotype was supported by our findings in three cellular/animal models: (i) thoc-2 gene knockout in C.elegans were almost completely immobile and thoc-2 +/− had impaired locomotion activity. The function of sensory neurones (AWA, AWB, AWC, ASE) was significantly impaired even in a mixed population of heterozygotes and thoc2 knockouts. (ii) In LC1 mouse neuronal precursors, downregulated Thoc2 (∼30% of the wild type) led to a significant increase in the proliferation, and (iii) in rat hippocampal primary neurones an increased length of neurites.
Overall, these data prove a neuronal defect driven by THOC2 suppression and suggest that THOC2 is a dosage-sensitive gene. Thus, THOC2 may represent a further member of nuclear mRNA export factors, whose inappropriate interaction, expression pattern and possibly mRNA-binding specificity are expected to produce a variety of congenital syndromes, associated with brain diseases.
In conclusion, we describe a female with a cerebellar hypoplasia-psychomotor delay syndrome in which a chromosomal translocation alters the expression of two genes, PTK2 and THOC2, involved in central nervous system. Our data and that of the literature suggest that the phenotype in our patient is due to the decreased expression of THOC2, or to a combined effect of THOC2/PTK2 reduction, although no definitive evidence exists in support of one of these two hypotheses.
